A precision medicine approach to the myelodysplastic syndrome with isolated deletion 5q, 50 years after its discovery.
Roncador M, Bernard E, Hasserjian R, Boultwood J, Elena C, Gallì A, Gurnari C, Mecucci C, Michaux L, Mittelman M, Sarchi M, Travaglino E, McLornan DP, Ogawa S, Papaemmanuil E, Hellström Lindberg E, Malcovati L, Cazzola M.
Roncador M, et al.
Blood. 2025 Oct 16;146(16):1883-1896. doi: 10.1182/blood.2025028619.
Blood. 2025.
PMID: 40758958
Review.
Haploinsufficiency production of multiple gene transcripts, primarily involving CSNK1A1, RPS14, MIR145, and MIR146A, results in myelodysplastic hematopoiesis. Lenalidomide can selectively suppress the del(5q)-mutant clone by promoting proteasomal degradation of casein kina …
Haploinsufficiency production of multiple gene transcripts, primarily involving CSNK1A1, RPS14, MIR145, and MIR146A, results in myelo …